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Background: Promyelocytic leukemia nuclear bodies (PML-NBs) have been depicted as structures which are involved
in processing cell damages and DNA double-strand break repairs. The study was designed to evaluate differences in
patients’ PML-NBs response to stress factors like a cancerous disease and ionizing radiation exposure dependent on age.
Methods: In order to clarify the role of PML-NBs in the aging process, we examined peripheral blood monocytes of
134 cancer patients and 41 healthy individuals between 22 and 92 years of age, both before and after in vitro irradiation.
Additionally, we analyzed the samples of the cancer patients after in vivo irradiation. Cells were immunostained and
about 1600 cells per individual were analyzed for the presence of PML- and γH2AX foci.
Results: The number of existing PML-NBs per nucleus declined with age, while the number of γH2AX foci increased with
age. There was a non-significant trend that in vivo irradiation increased the number of PML-NBs in cells of young study
participants, while in older individuals PML-NBs tended to decrease. It can be assumed that PML-NBs decrease in number
during the process of aging.
Conclusion: The findings suggest that there is a dysfunctional PML-NBs stress response in aged cells.
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Promyelocytic leukemia protein (PML) is part of a large
multiprotein nuclear complex known as promyelocytic
leukemia nuclear bodies (PML-NBs), which is associated
with the nuclear matrix [1]. Promyelocytic leukemia pro-
tein is involved in multiple cellular functions including
transcription, chromatin dynamics, oncogenesis, post-
translational modifications and DNA damage response
[2,3]. Additionally, PML plays a role in senescence and
ageing. PML is upregulated during cellular senescence
[4] and induces permanent cell cycle arrest via p53 and
retinoblastoma protein regulation [5]. At the same time,
PML is a dynamic sensor of DNA damage and cellular
stress [6] and it is involved in a later step of the DNA
double-strand break (DSB) repair [7]. In response to DNA
damage, the number of PML-NBs increases and these
PML-NBs alter their subnuclear location [7]. One type* Correspondence: Luitpold.Distel@uk-erlangen.de
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unless otherwise stated.of cellular stress is ionizing radiation due to its DNA
damaging properties. The number of DSBs identified as
γH2AX foci in peripheral blood monocytes is measured
in order to assess the stress triggered by irradiating the
cells. γH2AX foci are formed at the sites of DSB by the
phosphorylation of the H2A histone variant H2AX at
its amino acid serine 139 [8]. The ratio of visible γH2AX
foci to DSBs is close to 1:1, what makes the γH2AX im-
munofluorescent staining the most sensitive method
available for detecting DSBs in human cells [9]. Individual
differences in DSB repair can be obtained from interin-
dividual disparities in the number of γH2AX foci per
nucleus after in vitro irradiation and the subsequent
repair. The highest numbers of double strand breaks
per nucleus are visualized 30 minutes post irradiation.
The DSB number declines over a period of hours, while
the cells are repairing the DNA damage.
We evaluated the difference in patients’ PML response
to stress factors like cancer and radiotherapy treatment
dependent on age. We investigated the number of PML-
NBs in peripheral blood mononuclear cells of healthyl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and via ionizing radiation induced PML-NBs were studied.
As a measure of cellular stress, we compared the PML-
NBs with the number of DNA double-strand breaks.
Method
Patients characteristics
The prospective study included a total of 175 individuals. 66
rectal cancer patients (RC), 68 breast cancer patients (BC)
and 41 healthy participants were enrolled. The trial was in
compliance with the WMA Declaration of Helsinki - Ethical
Principles for Medical Research Involving Human Subjects.
All patients and healthy individuals gave their written
informed consent. This study was approved by the ethics re-
view committees of the Friedrich-Alexander-Universität
Erlangen-Nürnberg (No. 2725). The patients’ blood samples
were taken immediately before the first irradiation fraction
to yield the pre-existing background rates. After a daily frac-
tionated radiation treatment (5 × 1.8 Gy) and a free interval
of three days the second blood sample was taken (in vivo
irradiation). RC patients were treated with 5-fluoruracil
(5-FU) or a combination of 5-FU and oxaliplatin once a
week. BC patients received docetaxel, cyclophosphamide,
epirubicin or paclitaxel or a combination of these substances.
Some BC patients additionally received an antihormonal
therapy.
Blood samples and peripheral blood mononucleated cells
separation
The blood samples taken from patients prior to radioche-
motherapy (RCT) and the blood samples taken from con-
trol group were split into three samples. Two different
doses had to be used to irradiate the peripheral blood
mononucleated cells, because a dose of 2 Gy would induce
after 30 minutes such a high amount of foci so that they
could not be separated from each other and counted prop-
erly. There would remain only a very low number of foci
24 h after the low dose of 0.5 Gy and therefore the statistics
would be poor. Though the first sample was in vitro irradi-
ated using 0.5 Gy and afterwards incubated for 30 minutes.
This procedure was adopted for the second sample with
the difference of using 2 Gy and having a 24 h incubation
time. The third sample served as control. After five frac-
tions in vivo irradiation and the free interval of three days,
the fourth sample was taken. Two identical cover slips were
produced from each sample. Briefly, peripheral blood
mononucleated cells (PBMC) were isolated from heparin-
ized whole blood samples by Ficoll gradient centrifugation.
PBMC were maintained in RPMI 1640 medium supple-
mented with 1% penicillin-streptomycin and 10% fetal calf
serum. PBMC were divided into three samples, two were
in vitro irradiated and the third sample was used as a con-
trol. Afterwards, the blood samples were cytocentrifuged
(StatspinCytofuge, Kreatech, Germany) onto specimen. ThePBMC were fixed for 30 minutes in methanol and for one
minute in acetone before they were washed for 3x10 mi-
nutes in a phosphate-buffered saline with foetal calf serum.
Primary fibroblasts
A 2-mm punch skin biopsy was taken from the forearm of a
healthy Caucasian individual. The dermis was cut into small
pieces and placed in a small flask where it was covered with
F12 medium (Biochrom, Berlin, Germany) containing 20%
fetal calf serum. The outgrowing fibroblasts were trypsinized
and sub-cultured.
Antibodies and immunofluorescence analysis
One of the two identical cover slips of each approach was
then incubated with the mouse anti-γH2AX antibody
(Abcam, Cambridge, UK) and the second cover slip with
the rabbit anti-PML antibody (Santa Cruz, CA, USA).
Afterwards the cover slips were washed in PBS three times
and then incubated with a secondary goat anti-mouse
labeled with Alexa 488 fluorescent antibody or goat
anti-rabbit labeled with Alexa 594 fluorescent antibody
(Molecular Probes, Karlsruhe, Germany). Then, the sam-
ples were washed in PBS again three times and mounted
by using the Vectashield mounting medium (Vector
Laboratories, Peterborough, UK).
Fluorescence labeled blood cells were visualized by a
fluorescence-microscope (Axioplan 2, Zeiss, Göttingen,
Germany) and image acquisition software (Metafer 4,
MetaSystems, Altlußheim, Germany). Digital images of five
optical planes separated by a distance of 0.75 μm were
recorded and combined to an extended focus image using
the maximum intensity algorithm (Metasystems). An area of
2 mm2 (630×) was captured automatically. For each of the
samples 500 to 1000 cells were identified by using image
analysis software (Biomas, Erlangen, Germany). All nuclei
were morphologically considered by eye to be properly
shaped and cells in cell-division phase were excluded. By
using Biomas, the PML foci and the γH2AX foci inside each
nucleus were counted [10]. The number of mean residual
foci per cell was determined for every individual before
irradiation, 30 minutes after a dose of 0.5 Gy and 24 h after
a dose of 2 Gy. After the five fractions in vivo irradiation
and the free interval of three days the mean number of foci
per cell was counted again.
In vivo exposed dose
We evaluated two quantities to consider dose aspects: The
total deposit energy Edep and the mean dose Dmean, which
is the dose averaged over the whole body of the patient.
These quantities are strongly connected by a proportionality
relation:
Dmean ¼ Edepm ;
where m is the mass of the patient.
Figure 1 Study group characteristics. (A) Distribution by age and
gender for the group of patients and healthy individuals altogether,
(B) for the patient group with breast cancer, (C) the patient group
with rectal cancer and (D) healthy individuals.
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pk  Dpres: Vpk−Vpkþ1
  ρ;
where ρ is the mass density of the patient (ρ was
approximately set to 1 kg/dm3), Dpres. is the prescribed
dose and Vp is the isodose volume with at least a
percentage p of the prescribed dose. We used p in the
following percentage steps: 0.2, 0.3 0.4, 0.6, 0.8, 0.9 and
0.95. The different volumes Vp are achieved from
the dose distribution in the patients given by the treat-
ment planning system (Pinnacle, Philips, Fitchburg, WI,
USA).
Statistical analysis
The independent t-test was used to test for statistical
differences. With p < 0.05, differences were considered
statistically significant. Pearson correlation was used to
evaluate a possible correlation between PML-NBs fre-
quency per cell and time after exposure and between age
and focus formation. Statistical calculation was performed
by using SPSS version 19 (IBM, Ehningen, Germany).
Results
Study population
Our study group included a total of 175 individuals
(Figure 1A). Patients enrolled were between 22 and
92 years of age. Within this group 68 patients were with
breast cancer (BC) (Figure 1B), who received adjuvant
radiochemotherapy, and 66 patients with rectal cancer
(RC) (Figure 1C), who received neoadjuvant radiochemo-
therapy. The in vivo irradiation of RC patients included
five days of radiotherapy followed by a free interval of
three days (in vivo irradiation). The group of patients
included 54 males and 80 females. Our healthy group
consisted of 41 healthy individuals between 26 and
82 years of age. This group included 20 males and 21
females (Figure 1D). The clinical characteristics of the
study group are listed in Table 1.
γH2AX and PML foci in fibroblasts and PBMC
In order to investigate whether there are any differences in
fibroblast (Figure 2A) and PBMC (Figure 2B) PML and
γH2AX focus formation, we irradiated both types of cells
and measured the incidence of PML and γH2AX foci. In
fibroblasts the PML focus formation increased rapidly until
1 hour after irradiation using 2 Gy and the number of PML
foci rose slowly during the next 24 hours. In peripheral
blood monocytes the number increased during the first
hour and decreased very slowly throughout the follow-
ing 24 hours (Figure 2C). After irradiating peripheral
blood cells using 2 Gy, the count of γH2AX foci
formation reached its maximum after 30 minutes and
declined over the next hours (Figure 2D). The numberof γH2AX foci in fibroblasts reached its maximum
1 hour after irradiation and declined biphasic during
the following 12 hours.
Table 1 Patients’ characteristics
175 individuals
Healthy controls Rectal cancer patients n (%) Breast cancer patients (%)
n 41 66 68
Mean age 52.3a (±14.0a) 63.7a (±11.2a) 56.5a (±11.7a)
- cT2/cT3/cT4 2/61/3 (3.0/92.4/4.6) Tis/T1/T2/T3/T4 6/37/23/1/1
- cN0/cN+ 12/54 (18.2/81.8) N0/N+ 45/23
- cM0/cM1 54/12 (81.8/18.2) M0/M1 65/3
- Stage 3/4 58/8 (87.8/12.2) Dcis/no Dcis 38/30
- Mastectomy 9
Breast-preserving 59
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We used peripheral blood monocytes for the testing
because they can be taken easily from a large number
of individuals. Per individual 1600 cells in average were
analyzed. Samples were divided in equal parts for theFigure 2 Time dependence of PML-NBs induction after ionizing radia
before and after irradiation by X-rays stained with anti-γH2AX and anti-PML. T
cells using 2 Gy were counted at different times after irradiation. The black tria
correlation coefficients (r) and the p-values for the linear function are given (C(I.) pre-existing PML-NB frequency, (II.) the initial
PML foci count after 0.5 Gy and 30 min, (III.) after a
24 h recovery time with 2 Gy and (IV.) after an in vivo
irradiation. No difference was seen in the existing number
of PML-NBs per cell between the healthy individualstion. Fluorescence microscopic images of (A) fibroblasts and (B) PBMC
he number of PML-NBs (C) and number of γH2AX foci (D) in irradiated
ngles represent fibroblasts and the white squares PBMC’s. Pearson’s
).
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(Figure 3A). Within these groups large interindividual
differences could be detected.
Number of PML-NBs without and after various radiation
intensities
To determine if radiation induces PML-NBs, we used var-
ied radiation doses. There was no significant difference
found between the incidence of existing PML-NBs per cell
and the number counted after irradiation with 0.5 Gy and
30 minutes repair time. The incidence of PML-NBs after
irradiation with 2 Gy and 24 hours repair time and the
number of PML-NBs after 1 week of radiotherapy and
3 days repair time also do not differ significantly from any
other experimental approach (Figure 3B).
PML-NBs per cell decrease with donor age
To determine whether age affects the incidence of PML-
NBs, we looked at the nuclei of PBMC from 175 donors
aged 22 to 92 years. The mean number of PML-NBs
per cell decreases linearly with increasing age at an
equivalent level in the control population (−0.0091
PML-NBs per year) and the patient groups (−0.0100
PML-NBs per year) (Figure 3C). The healthy participants
and patients were grouped together due to their similar
age dependency. Sub-groups comprising ten years of age
were formed. The number of PML foci per cell declined
significantly (p = 0.03) between the sub-group of 70 to
80 year old individuals compared to the sub-group of
40 to 50 year old individuals and the individuals older
than 70 years had statistical significant lower PML-NBs
than the study group younger than 50 years (p = 0.01)
(Figure 3D).
γH2AX foci per cell increase with donor age
The linking between PML-NBs and the DNA-damage
repair suggests that the decreasing number of PML-NBs
leads to an increasing number of γH2AX foci. To inves-
tigate the effect of age on the number of γH2AX foci,
we used PBMC from the same 175 donors. A growing
number of γH2AX foci with increasing age of the patient
could be seen (0.0029 γH2AX foci per year). Similarly,
the healthy individuals group showed a slight increase as
well (0.0007 γH2AX foci per year) (Figure 3E). In the
sub-group of 50 to 60 year old patients the number of
γH2AX foci per cell nucleus was significantly (p = 0.01)
lower than in the sub-group of 60 to 70 year old patients
(Figure 3F).
PML-NBs per cell increase in young and decrease in older
individuals after RT
At the age of 40 years and younger the cancer patients’
number of PML-NBs per cell increased after in vivo irradi-
ation compared to the pre-existing PML foci (p = 0.15).PBMC from cancer patients aged 70 years and older were
found to have higher rates of the pre-existing PML-NBs
per cell. After in vivo irradiation the number of PML-NBs
tended to decrease (p = 0.19). However this variation
was not significant. In total, the number of PML-NBs
decreased with the donor’s age for the pre-existing PML-
NBs as for the values after in vivo irradiation (Figure 3G).
The number of PML-NBs per cell after in vitro irradiation
declined significantly (p < 0.001) between the sub-groups
of 70 to 80 year old individuals compared to the sub-
group of 40 to 50 year old individuals. These effects of
in vivo irradiation cannot be explained by possible differ-
ent doses exposed to the groups of donors with different
age. Using Dmean and Edep to quantify the doses received
in Figure 3H, I, it clearly shows that for the 40 to over
80 year old patients the doses are slightly increasing rather
than decreasing with age.
Discussion
One of the major causes of cell aging seems to be impaired
repair of DNA damage as a result of changes in cellular
stress response which lead to an accumulation of DNA
damage [11]. However, there must be several factors
leading to dysfunctional DNA repair in aged cells. We
were interested in PML because of its involvement in
DNA damage repair and stress response. Our major
findings are: (i) PML-NBs decrease in PBMC with in-
creasing age of individuals. At the same time the cellular
stress increases, which was proved by an accumulation of
γH2AX foci in dependence of age. (ii) PML-NBs arise in
individuals younger than 50 years after exposure to in vivo
ionizing radiation. As opposed to this, individuals over
70 years of age show a decrease in the number of PML-
NBs as a response to in vivo ionizing radiation. There
seems to be an impaired PML-NBs stress response in the
aged cell. To our knowledge, so far no clinical data exist
which depict the age related PML-NBs induction and a
limited PML-NB stress response in older individuals.
The impaired stress response in aged cells might be
related to the accumulation of DNA damage [12]. The
DNA repair is related to PML-NBs in several ways [1].
Gamma-irradiation results in the recruitment of p53 to
PML-NBs as one aspect of PML-NBs being involved in
DNA repair through several repair proteins [6]. PML-NBs
are reported to facilitate the homology-directed repair
by interacting with DNA repair proteins such as Rad51
or BML. It makes DSB repair more efficient by facilitat-
ing to localize and stabilize Rad51. It is suggested that
PML-NBs are involved in processing double-strand breaks,
generating ssDNA tails, which are essential for the assem-
bly of DNA repair protein complexes [2]. PML-NBs may
have the ability to act as sensors of cellular stress [6].
Although it might be that the accumulation of γH2AX
foci is in part a result of the decreased and impaired
Figure 3 (See legend on next page.)
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Figure 3 PML-NBs depending on individuals’ age. (A) PML-NBs per cell in patients with breast cancer and rectal cancer as well as healthy
individuals. (B) Mean number of PML-NBs per cell without irradiation, after 0.5 Gy and 30 minutes repair time, after 2 Gy and 24 hours repair
time and three days after one week of radiochemotherapy. (C) PML-NBs per cell dependent on age. Patients are represented by squares and
the healthy individuals by circles. A linear fit was used. Patients are depicted by the solid line and healthy individuals by the dashed line. (D) The mean
PML-NBs per cell of cancer patients and healthy individuals within groups comprising ten years of age are represented by squares. (E) Pre-existing
γH2AX foci per cell in dependence of age in healthy individuals (squares) and patients (circles). (F) The mean γH2AX foci per cell of patients within
groups comprising 10 years of age are represented by squares. There is a significant (p = 0.01) increase in γH2AX per cell between the group comprising
50 to 60 year-old study participants and the group including 60 to 70-year-old individuals. (G) Patients PML-NBs per cell divided into age groups
comprising ten years of age. The solid line depicts the pre-existing PML-NBs per cell and the dashed line PML-NBs three days after one week of
radiochemotherapy. (H) Dmean and (I) Edep in dependence of age comprised in ten-year periods. Error bars depict the standard deviation of the mean.
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there is a relation between the aging of the cell and the
decrease of PML-NBs and it might be related to the
change in stress response.
We compared the pre-existing number of PML-NBs
per cell in patients suffering from cancer and healthy
controls. There was no significant difference in the
number of PML-NBs between both groups. Therefore,
the decline in the number of PML-NBs seems not to be
related with the presence of cancer. Having compared
the PML-NBs level in individuals at different ages, we
made the observation that increased levels of γH2AX
foci coincide with a decrease of PML-NBs in aged cells.
An additional support of the thesis that there seems
to be an impaired PML-NBs regulation in dependence
of age is that in patients younger than 50 years there
was a trend to an increase of PML-NBs after a in vivo
irradiation. The irradiation consisted of 1.8 Gy daily,
five times for one week and three additional days. Quite
in contrast to it the individuals between 50 and 70 years
old had no change in the number of PML-NBs. Patients
older than 70 years even had a reduced number of PML
NBs after in vivo irradiation.
The PML-NB increase is caused by transcriptional up-
regulation [13] or fission [3], which results in clear and
stable foci, which were made visible by immunostaining.
The equally bright PML foci are easy to quantify by high
throughput analyses. There is a clear difference of the
PML-NBs number between lymphocytes and fibroblasts.
Lymphocytes have about 2.5 PML-NBs per cell, while
fibroblasts have about 10 PML-NBs per cell. In both
cell types PML-NBs rapidly increase in the first three
hours after exposure to ionizing radiation. PML-NBs in the
lymphocytes decrease very slowly thereafter. In contrary in
fibroblasts there is long lasting increase of PML-NBs after
stress induction. It might be of higher priority to study the
more prominent effect in fibroblasts. However, human
PBMC were used for the testing. The advantage of PBMC
is that all cells are in G0/G1 phase of cell cycle and so
there are no problems arising from the variation of
PML-NBs number depending on cell cycle. The disad-
vantage of PBMC is the low number of PML-NBs and
the cells spheroid shape and the resulting problems tocount the foci in different planes of the cell. However
this can be overcome by acquiring multiple planes by
the microscope and fuse it to a single image. Additionally
it would have been difficult to have skin biopsies of
such a large number of donors and it would not have
been possible to yield skin biopsies after one week of
RCT. It could be assumed that the presence and alteration
of PML-NBs is similar in all cells of the body.
It could be hypothesized that PML monitors a basic
aging process and not the effects of a disease [14]. To prove
this, we showed that cancer patients have no significant
difference in the number of PML-NBs compared to healthy
individuals. Since the accumulation of DNA damage is one
of the main characteristics of aging [15], it can be assumed
that aging might be in some way involved in the DNA
repair process. The roles of PML as a sensor of cellular
stress and a mediator of DNA damage response is strongly
implied by a series of observations made in past studies.
PML-NBs were found to be sensitive detectors of cellular
stress [3]. Between PML-NBs and DNA repair links have
been made, e.g. PML is supposed to have a role in coord-
ination of DSB processing [1]. To support this hypothesis
it might be useful to study PML-NBs in animal aging
models in the future [16,17].Conclusion
The results of our study were generated from a significant
number of donors and provide the compelling evidence
that there is a dysfunctional stress response in aged in-
dividuals. The loss of PML-NBs in number and their
impaired stress response seems to be a pathological
reaction caused by cell aging. It can be hypothesized
that the accumulation of cell damage with increasing age
is at least in part caused by an impaired stress response
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